Document:

EX-4.2

 Exhibit 4.2 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (the “Agreement”) is made as of February 6, 2015, by and
among Oportun Financial Corporation (the “Company”), the common stockholders listed on Schedule A hereto (the “Common Holders”), the investors listed on Schedule B through Schedule J hereto (the
“Investors”) and the holders of the BlackRock Warrants and the Hercules Warrants (each as defined below) (the “Warrant Holders”). 

RECITALS 

WHEREAS, the Company, the Common Holders and certain of the Investors (the “Prior Investors”) are parties to that
certain Amended and Restated Investor Rights Agreement dated as of August 28, 2013 (the “Prior Agreement”); 

WHEREAS, the Prior Agreement may be amended only with the written consent of the Company and the holders of at least a majority of the
Registrable Securities (as defined in the Prior Agreement) then outstanding; 
 WHEREAS, certain provisions of the Prior Agreement
may be amended only with the written consent of the Company and (i) the Prior Investors holding at least a majority of the Registrable Securities (as defined in the Prior Agreement) then held by all Prior Investors and/or (ii) the holders
of at least a majority interest of the Major Investors (as defined in the Prior Agreement) based on the number of shares of Registrable Securities (as defined in the Prior Agreement) then held by the Major Investors (as defined in the Prior
Agreement); 
 WHEREAS, the Investors listed on Schedule J hereto (the “Series H Investors”) are parties to the
Series H Preferred Stock Purchase Agreement of even date herewith, by and among the Company and the Series H Investors (the “Series H Agreement”), pursuant to which the Series H Investors shall invest funds in the Company (the
“Financing”); and 
 WHEREAS, in order to induce the Company to enter into the Series H Agreement and to induce the
Series H Investors to invest funds in the Company pursuant to the Series H Agreement, (i) the holders of a majority of the Preferred Stock (as defined in the Prior Agreement) currently outstanding (voting together on an as-converted to Common Stock basis) and (ii) the Common Holders representing a majority-in-interest of the shares of Common Stock
held by all Common Holders currently providing services to the Company as an officer, employee, or consultant hereby agree to waive their rights under the Prior Agreement and enter into this Agreement in order to amend and restate the Prior
Agreement. 
 NOW, THEREFORE, in consideration of these promises and the mutual promises set forth in this Agreement, the
parties hereby amend and restate the Prior Agreement as follows: 
 1. Prior Agreement and Waiver. The parties hereto agree that the
Prior Agreement shall be superseded and replaced in its entirety by this Agreement. The Prior Investors and Warrant Holders each waive the right of first offer, as set forth in Section 3.4 of the Prior Agreement, or any other investment rights
with respect to the sale and issuance of Series H Preferred Stock pursuant to the Series H Agreement. 
 2. Registration Rights. The
Company covenants and agrees as follows: 
 2.1 Definitions. For purposes of this Section 2: 

(a) The term “Act” means the Securities Act of 1933, as amended. 

(b) The term “Form S-3” means such form under the Act as in effect on the date hereof
or any registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

  
 1. 

 (c) The term “Holder” means any Investor and, except with respect to Sections
2.2, 2.12, 2.13 and Section 3 below, the Common Holders owning or having the right to acquire Registrable Securities or any assignee thereof in accordance with Section 2.13 below. 

(d) The term “1934 Act” shall mean the Securities Exchange Act of 1934, as amended. 

(e) The terms “register,” “registered” and “registration” each refer to a registration
effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document. 

(f) The term “Preferred Stock” means the Company’s Series A-1 Preferred Stock,
Series B-1 Preferred Stock, Series C-1 Preferred Stock, Series D-1 Preferred Stock, Series
E-1 Preferred Stock, Series F Preferred Stock, Series F-1 Preferred Stock, Series G Preferred Stock and Series H Preferred Stock. 

(g) The term “Registrable Securities” means: (i) the Common Stock issued or issuable upon conversion of the Preferred
Stock of the Company, but excluding the shares of Common Stock issued upon conversion of the Preferred Stock for any reason other than pursuant to a Qualified Public Offering (as defined in the Company’s Certificate of Incorporation) prior to
the date of this Agreement; (ii) other than with respect to Sections 2.2, 2.12, 2.13 and Section 3 below, any Common Stock held by the Common Holders as of the date hereof; (iii) the Common Stock issued or issuable upon exercise of a
warrant to purchase Common Stock dated July 26, 2011 (the “BlackRock Warrant”) issued to BlackRock Kelso Capital Corporation (“BlackRock”) and any other warrants to purchase Common Stock issued pursuant to any
transfer in whole or in part, directly or remotely, of the BlackRock Warrant (collectively with the BlackRock Warrant, the “BlackRock Warrants”), provided that for purposes of this Section 2, BlackRock shall be deemed to own
and hold all of the Common Stock issued or issuable upon exercise of the BlackRock Warrants; (iv) the Common Stock issued or issuable upon conversion of any Preferred Stock issued or issuable upon exercise of the warrants to purchase such
Preferred Stock, each dated June 28, 2013 and July 29, 2013 issued to Hercules Technology Growth Capital, Inc. (“Hercules”) or issued pursuant to any transfer in whole or in part, directly or remotely, of such warrants
(collectively, the “Hercules Warrants”); and (v) any Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution
with respect to, or in exchange for, or in replacement of, the securities set forth in subsection (i), (ii), (iii) or (iv) above, excluding, however, any Registrable Securities sold by a person in a transaction in which such person’s
rights under this Section 2 are not assigned. In addition, Common Stock or other securities shall only be treated as Registrable Securities if and so long as they have not been (A) sold to or through a broker or dealer or underwriter in a
public distribution or a public securities transaction, including sales made pursuant to Rule 144 promulgated under the Act, or (B) sold in a transaction exempt from the registration and prospectus delivery requirements of the Act under
Section 4(1) thereof so that all transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale. 

(h) The number of shares of “Registrable Securities then outstanding” shall mean the number of shares of Common Stock that
are Registrable Securities and (i) are then issued and outstanding or (ii) are then issuable pursuant to the exercise or conversion of then outstanding and then exercisable options, warrants or convertible securities (including, without
limitation, the Preferred Stock). 
 (i) The term “SEC” shall mean the Securities and Exchange Commission. 

2.2 Request for Registration. 

(a) If the Company shall receive at any time after the earlier of (i) five (5) years after the date hereof, and (ii) one-hundred eighty (180) days after the effective date of the first registration statement for an underwritten public offering of the Company’s Common Stock, a written request from the Holders of
at least twenty percent (20%) of the Registrable Securities then outstanding (or a lesser percentage if the aggregate offering price to the public is not less than ten million dollars ($10,000,000)) that the Company shall use its best efforts to
file a registration statement under the Act covering the registration of securities, then the Company shall: 

  
 2. 

 (i) within twenty (20) days of the receipt thereof, give written notice of such request to
all Holders; and 
 (ii) use its best efforts to effect as soon as practicable the registration under the Act of all Registrable Securities
that the Holders request to be registered (including Holders not part of the registration request if written request is received within twenty (20) days of the Company’s notice), subject to the limitations of subsection 2.2(b). 

(b) If the Holders initiating the registration request hereunder (the “Initiating Holders”) intend to distribute the
Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to subsection 2.2(a) and the Company shall include such information in the written notice referred
to in subsection 2.2(a). The underwriter will be selected by a majority in interest of the Initiating Holders and shall be reasonably acceptable to the Company. In such event, the right of any Holder to include such Holder’s Registrable
Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in
interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall (together with the Company as provided in subsection 2.4(e)) enter into an
underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of this Section 2.2, if the underwriter advises the Initiating Holders in writing that marketing
factors require a limitation of the number of shares to be underwritten (including Registrable Securities), then the Initiating Holders shall so advise all Holders of Registrable Securities that would otherwise be underwritten pursuant hereto, and
the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all Holders thereof, including the Initiating Holders, in proportion (as nearly as practicable) to the amount of Registrable Securities
of the Company owned by each Holder; provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all securities other than Registrable Securities are first entirely excluded
from the underwriting. 
 (c) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a registration statement
pursuant to this Section 2.2, a certificate signed by the President or Chief Executive Officer of the Company stating that in the good faith judgment of the Board of Directors of the Company (the “Board”), it would be seriously
detrimental to the Company and its stockholders for such registration statement to be filed, the Company shall have the right to defer taking action with respect to such filing for a period not to exceed ninety (90) days after receipt of the
request of the Initiating Holders; provided such right may not be exercised more than once in any twelve (12) month period. 
 (d) In
addition, the Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to this Section 2.2: 

(i) After the Company has effected two (2) registrations pursuant to this Section 2.2 and such registrations have been declared or
ordered effective; 
 (ii) During the period starting with the date sixty (60) days prior to the Company’s good faith estimate of
the date of filing of, and ending on a date one hundred eighty (180) days after the effective date of the first registration statement for a firm commitment underwritten public offering of the Company’s Common Stock (the “IPO”);
provided that the Company delivers notice to the Initiating Holders within thirty (30) days of any such registration request and the Company is actively employing in good faith all reasonable efforts to cause such registration statement to
become effective; or 

  
 3. 

 (iii) If the Initiating Holders propose to dispose of shares of Registrable Securities that may
be immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.12 below. 

2.3 Company Registration. If (but without any obligation to do so) the Company proposes to register for its own account, or the account
of others, any of its capital stock or other securities under the Act in connection with the public offering of such securities solely for cash (other than a registration relating solely to the sale of securities to participants in a Company stock
plan, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities or a registration in which the only Common
Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered or a registration relating solely to an SEC Rule 145 transaction), the Company shall, at such time, promptly give each Holder written
notice of such registration. Upon the written request of each Holder given within twenty (20) days after deemed receipt by such Holder of such notice by the Company in accordance with Section 4.5, the Company shall, subject to the
provisions of Section 2.8, use its best efforts to cause to be registered under the Act all of the Registrable Securities that each such Holder has requested to be registered. 

2.4 Obligations of the Company. Whenever required under this Section 2 to effect the registration of any Registrable Securities,
the Company shall, as expeditiously as reasonably possible: 
 (a) Prepare and file with the SEC a registration statement with respect to
such Registrable Securities and use its best efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement
effective for a period that is the shorter of up to one hundred twenty (120) days or until the distribution contemplated in the Registration Statement has been completed; provided, however, that (i) such 120-day period shall be extended for a period of time equal to the period the Holder refrains from selling any securities included in such registration at the request of an underwriter of Common Stock (or other
securities) of the Company; and (ii) in the case of any registration of Registrable Securities on Form S-3 that are intended to be offered on a continuous or delayed basis, such 120-day period shall be extended, if necessary, to keep the registration statement effective until all such Registrable Securities are sold, provided that Rule 415, or any successor rule under the Act, permits an
offering on a continuous or delayed basis. 
 (b) Prepare and file with the SEC such amendments and supplements to such registration
statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement for up to one
hundred twenty (120) days, or until the distribution described in such registration statement is completed, if earlier. 
 (c) Furnish
to the Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable
Securities owned by them. 
 (d) Use its best efforts to register and qualify the securities covered by such registration statement under
such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided, that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to
file a general consent to service of process in any such states or jurisdictions, except as may be required by the Act. 
 (e) In the event
of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter
into and perform its obligations under such an agreement. 

  
 4. 

 (f) Notify each Holder of Registrable Securities covered by such registration statement at any
time when a prospectus relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a
material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing. The Company will use its commercially reasonable efforts to
amend or supplement such prospectus to cause such prospectus not to include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the
light of the circumstances then existing. 
 (g) Cause all such Registrable Securities registered hereunder to be listed on a national
exchange or trading system and each securities exchange on which similar securities issued by the Company are then listed. 
 (h) Provide a
transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration. 

(i) Furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this Section 2, on the date that
such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant to this Section 2, if such securities are being sold through underwriters, or, if such securities are not being sold through
underwriters, on the date that the registration statement with respect to such securities becomes effective, (i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance
as is customarily given to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities, and (ii) if such securities are being sold through
underwriters, a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering,
addressed to the underwriters. 
 2.5 Furnish Information. It shall be a condition precedent to the obligations of the Company to take
any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended
method of disposition of such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 

2.6 Expenses of Demand Registration. All expenses (other than underwriting discounts and commissions) incurred in connection with
registrations, filings or qualifications pursuant to Section 2.2, including (without limitation) all registration, filing and qualification fees, printers’ and accounting fees, and fees and disbursements of counsel for the Company and one
(1) counsel to the Holders (such expenses of counsel to the Holders shall not exceed twenty thousand dollars ($20,000)) shall be borne by the Company; provided, however, that the Company shall not be required to pay for any
expenses of any registration proceeding begun pursuant to Section 2.2 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all
participating Holders shall bear such expenses), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 2.2; provided further, however,
that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with
reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 2.2. 

2.7 Expenses of Company Registration. The Company shall bear and pay all expenses incurred in connection with any registration, filing
or qualification of Registrable Securities with respect to the registrations pursuant to Section 2.4 for each Holder (which right may be assigned as provided in Section 2.13), including (without limitation) all registration, filing, and
qualification fees and printers’ and accounting fees, the fees and expenses of counsel for the Company and one (1) counsel for the Holders (such expenses of counsel to the Holders shall not exceed twenty thousand dollars ($20,000)), but
excluding underwriting discounts and commissions relating to Registrable Securities. 

  
 5. 

 2.8 Underwriting Requirements. If a registration statement for which the Company gives
notice pursuant to Section 2.3 is for an underwritten offering, then the Company shall so advise the Holders of Registrable Securities. In such event, the right of any Holder’s Registrable Securities to be included in a registration
pursuant to Section 2.3 shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to
distribute their Registrable Securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriter(s) selected for such underwriting. Notwithstanding any other provision of
this Agreement, if the managing underwriter(s) determine(s) in good faith that marketing factors require a limitation of the number of shares to be underwritten, then the managing underwriter(s) may exclude shares (including Registrable Securities)
from the registration and the underwriting, and the number of shares that may be included in the registration and the underwriting shall be allocated first, to the Company, second, to each of the Holders (other than any Holder who is
also a Common Holder) requesting inclusion of their Registrable Securities in such registration statement on a pro rata basis based upon the total number of Registrable Securities then held by each such Holder, third, to each Holder who is
also a Common Holder requesting inclusion of his Registrable Securities in such registration statement on a pro rata basis based upon the total number of Registrable Securities then held by each Holder who is also a Common Holder, and fourth,
to any other securityholder; provided, however, that the right of the underwriters to exclude shares (including Registrable Securities) from the registration and underwriting as described above in this Section 2.8 shall be
restricted so that: (i) the number of Registrable Securities then held by the Investors included in any such registration is not reduced below thirty percent (30%) of all the shares included in the registration, except for a registration
relating to the Company’s initial public offering of its Common Stock, from which all Registrable Securities may be excluded, and (ii) all shares held by securityholders that are not Registrable Securities shall first be excluded from such
registration and underwriting before any Registrable Securities are so excluded, unless holders of a majority of the Registrable Securities then outstanding approve the inclusion of such shares held by securityholders that are not Registrable
Securities. If any Holder disapproves of the terms of any such underwriting, such Holder may elect to withdraw therefrom by written notice to the Company and the underwriter, delivered at least twenty (20) business days prior to the effective
date of the registration statement. Any Registrable Securities excluded or withdrawn from such underwriting shall be excluded and withdrawn from the registration. For any Holder that is a venture capital fund, partnership or corporation, the
affiliated venture capital funds, partners, retired partners and stockholders of such Holder, or the estates and family members of any such partners, stockholders and retired partners and any trusts for the benefit of any of the foregoing persons
shall be deemed to be a single “Holder,” and any pro rata reduction with respect to such “Holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in
such “Holder,” as defined in this sentence. 
 2.9 Delay of Registration. No Holder shall have any right to obtain or seek
an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.10 Indemnification. In the event any Registrable Securities are included in a registration statement under this Section 2: 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, any underwriter (as defined in the Act) for such
Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act
or other federal or state law, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a
“Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any

  
 6. 

 
amendments or supplements thereto; (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not
misleading; or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities law or any rule or regulation promulgated under the Act, the 1934 Act or any state securities law; and the Company will pay to
each such Holder, underwriter or controlling person, as incurred, any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action; provided,
however, that the indemnity agreement contained in this subsection 2.10(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company
(which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon
and in conformity with written information furnished by any such Holder, underwriter or controlling person expressly for use in connection with such registration. 

(b) To the extent permitted by law, each selling Holder will, severally and not jointly, indemnify and hold harmless the Company, each of its
directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, any underwriter, any other Holder selling securities in such registration statement and any
controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Act, the 1934 Act or other federal or state law,
insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity
with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will pay, as incurred, any legal or other expenses reasonably incurred by any person intended to be indemnified pursuant
to this subsection 2.10(b), in connection with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the indemnity agreement contained in this subsection 2.10(b) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided, that in no event shall any indemnity
under this subsection 2.10(b) exceed the net proceeds from the offering received by such Holder. 
 (c) Promptly after receipt by an
indemnified party under this Section 2.10 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this
Section 2.10, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other
indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented
without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party
would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a
reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of liability to the indemnified party under this Section 2.10 to the extent of such prejudice,
but the omission to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 2.10. 

(d) If the indemnification provided for in this Section 2.10 is held by a court of competent jurisdiction to be unavailable to an
indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with
the statements or omissions that resulted in such loss, liability, claim, damage or expense 

  
 7. 

 
as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission; provided, however, that in no event shall any contribution by a Holder hereunder, when taken together with any indemnification by such Holder pursuant to
Section 2.10(b), exceed the net proceeds from the offering received by such Holder, except in the case of willful fraud by such Holder. 

(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control; provided, however, that to the extent the
underwriting agreement does not address a matter addressed by this Agreement, the failure to address such matter shall not be deemed a conflict between the provisions of this Agreement and the underwriting agreement. 

(f) The obligations of the Company and Holders under this Section 2.10 shall survive the completion of any offering of Registrable
Securities in a registration statement under this Section 1, and otherwise. 
 2.11 Reports Under the 1934 Act. With a view to
making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a
registration on Form S-3, the Company agrees to: 
 (a) make and keep public information available,
as those terms are understood and defined in SEC Rule 144, at all times after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public; 

(b) take such action, including the voluntary registration of its Common Stock under Section 12 of the 1934 Act, as is necessary to
enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement
filed by the Company for the offering of its securities to the general public is declared effective; 
 (c) file with the SEC in a timely
manner all reports and other documents required of the Company under the Act and the 1934 Act; and 
 (d) furnish to any Holder, so long as
the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of
the first registration statement filed by the Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies); (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents filed under the 1934 Act by the Company; and (iii) such
other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 

2.12 Form S-3 Registration. If the Company shall receive from any Holder or Holders a written
request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders,
the Company will: 
 (a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all
other Holders; and 

  
 8. 

 (b) use its best efforts to effect, as soon as practicable, such registration and all such
qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such request, together with
all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Company;
provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 2.12: (i) if Form S-3 is not available for
such offering by the Holders; (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an
aggregate price to the public (net of any underwriters’ discounts or commissions) of less than one million dollars ($1,000,000); (iii) if the Company shall furnish to the Holders a certificate signed by the President or Chief Executive Officer
of the Company stating that in the good faith judgment of the Board, it would be seriously detrimental to the Company and its stockholders for such Form S-3 registration to be effected at such time, in which
event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period not to exceed ninety (90) days after receipt of the request of the Holder or Holders under
this Section 2.12, provided, that such right may not be exercised more than once in any twelve (12)-month period; (iv) if the Company has, within the twelve (12) month period preceding the date of such request, already effected
two (2) registration on Form S-3 for the Holders pursuant to this Section 2.12; or (v) in any particular jurisdiction in which the Company would be required to qualify to do business or to
execute a general consent to service of process in effecting such registration, qualification or compliance. 
 (c) Subject to the
foregoing, the Company shall file a registration statement covering the Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders. All expenses incurred
in connection with registrations requested pursuant to Section 2.12, including (without limitation) all registration, filing, qualification, printers’ and accounting fees and the fees and disbursements of counsel for the Company and fees
and expenses for one (1) special counsel for the Holders (such expenses of counsel to the Holders shall not exceed twenty thousand dollars ($20,000)), but excluding any underwriters’ discounts or commissions, associated with Registrable
Securities, shall be borne by the Company. Registrations effected pursuant to this Section 2.12 shall not be counted as demands for registration or registrations effected pursuant to Section 2.2 or Section 2.3. 

(d) The Company shall not be obligated to effect any registration pursuant to this Section 2.12 if the Company delivers to the Holders
requesting registration under this Section 2.12 an opinion, in form and substance reasonably acceptable to such Holders, of counsel reasonably satisfactory to such Holders, that all Registrable Securities so requested to be registered may be
sold or transferred pursuant to Rule 144(k) under the Act. 
 2.13 Assignment of Registration Rights. The rights to cause the Company
to register Registrable Securities pursuant to this Section 2 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities provided: (a) the Company is, within a reasonable time
after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; (b) such transferee or assignee agrees in writing to
be bound by and subject to the terms and conditions of this Agreement, including without limitation the provisions of Section 2.14 below; (c) the transfer involves a transfer of at least fifty thousand (50,000) shares of Registrable
Securities (as adjusted for dividends, splits, recapitalizations and the like); provided, however, that transfers or assignments to partners, limited partners, retired or former partners, members, former members, stockholders, parents,
children, spouses, siblings, trusts or affiliates of a Holder shall be without restriction as to the minimum number of shares to be transferred; and (d) such assignment shall be effective only if immediately following such transfer the further
disposition of such securities by the transferee or assignee is restricted under the Act. 

  
 9. 

 2.14 “Market Stand-Off” Agreement. Each
Holder hereby agrees that, during the period of duration specified by the Company and an underwriter of Common Stock or other securities of the Company, following the effective date of a registration statement of the Company filed under the Act
pertaining to the IPO, it shall not, to the extent requested by the Company or such underwriter, (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether such shares or any such
securities are then owned by the Holder or are thereafter acquired), or (ii) enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock,
whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise; provided, however, that: 

(a) such agreement shall be applicable only to the IPO and, with respect to the Series H Investors, only to securities of the Company held by
such Series H Investors immediately prior to the effectiveness of the registration statement; 
 (b) all executive officers, directors and
holders of one percent (1%) or more of the outstanding Common Stock (on an as-converted to Common Stock basis) of the Company enter into similar agreements; 

(c) such agreement shall provide that any discretionary releases from the lock-up be allocated to all
holders of Registrable Securities on a pro-rata basis; and 
 (d) such market stand-off time period shall not exceed one hundred eighty (180) days or any longer period needed to facilitate compliance with applicable FINRA rules. 

In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of
each Investor (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. Each Holder agrees to execute such agreements as may be reasonably requested by the underwriters in connection with
an IPO that are consistent with this Section 2.14. For the purposes of this Section 2.14, Holders shall include the holders of any Registrable Securities. 

Notwithstanding the foregoing, the obligations described in this Section 2.14 shall not apply to a registration relating solely to
employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration relating solely to an SEC Rule 145 transaction.

 2.15 Termination of Registration Rights. No Holder shall be entitled to exercise any right provided for in Section 1 after the
earlier of: (a) four (4) years following the consummation of the IPO or (b) as to any particular Holder, following the IPO and expiration of the restrictions described in Section 2.14 above, at such time as such Holder and its
affiliates hold Registrable Securities in aggregate representing less than 1% of the Company’s outstanding Common Stock and all Registrable Securities held by such Holder and its affiliates may immediately be sold in any three (3) month
period without registration under SEC Rule 144. 
 2.16 Limitations on Subsequent Registration Rights. From and after the date of this
Agreement, the Company shall not, without the prior written consent of the Investors holding a majority of the Registrable Securities held by all Investors, enter into any agreement with any holder or prospective holder of any securities of the
Company giving such holder or prospective holder any registration rights the terms of which are senior to or on parity with the registration rights granted to the Investors hereunder. 

3. Covenants of the Company. 

3.1 Delivery of Financial Statements. The Company shall deliver to each of (i) BlackRock and (ii) any Investor that
(x) holds (together with its affiliates) at least three million nine hundred fifty thousand (3,950,000) shares of Registrable Securities (as adjusted for dividends, splits, recapitalizations and the like), or (y) has purchased and
continues to hold at least $4,000,000 of Preferred Stock, valued at the respective initial purchase price of such Preferred Stock (each such Investor and together with Blackrock, a “Major Investor”; provided, however,
that in the event a majority of the shares 

  
 10. 

 
of Preferred Stock held by a Major Investor, other than a Series H Investor, are converted into shares of Common Stock for any reason other than pursuant to a Qualified Public Offering (as
defined in the Company’s Certificate of Incorporation), such holder shall cease to be a “Major Investor” for purposes of this Agreement immediately upon such conversion): 

(a) as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the Company and its
subsidiaries (if any), or such later date as the Board shall approve, a consolidated income statement for such fiscal year, a consolidated balance sheet of the Company as of the end of such year, a consolidated statement of stockholder’s equity
as of the end of such year and a statement of cash flows for such fiscal year, such year-end financial reports will be unaudited and shall be prepared in accordance with generally accepted accounting
principles (“GAAP”); 
 (b) as soon as practicable, but in any event within one hundred-eighty (180) days after the
end of each fiscal year of the Company and its subsidiaries (if any), or such later date as the Board shall approve, a consolidated income statement for such fiscal year, a consolidated balance sheet of the Company as of the end of such year, a
consolidated statement of stockholder’s equity as of the end of such year and a statement of cash flows for such fiscal year, such year-end financial reports shall be audited and certified by a national
accounting firm selected by the Company and prepared in accordance with generally accepted accounting principles (“GAAP”); 

(c) as soon as practicable but in no event more than sixty (60) days after the end of each of the first three quarters of each fiscal
year of the Company and its subsidiaries (if any), an unaudited consolidated income statement, balance sheet and statement of cash flows for and as of the end of each such quarter, such unaudited financial statements to be in reasonable detail and
in accordance with GAAP (other than accompanying notes), subject to changes result from year-end audit adjustments; and 

(d) upon the request of such Major Investor and for as long as the Board requests the following financial statements, as soon as practicable
but in no event more than fifteen (15) days after the end of each month of each fiscal year of the Company, an unaudited income statement as of the end of each such month, such unaudited financial statements to be in reasonable detail. 

3.2 Inspection Rights. 

(a) The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s properties,
to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by such Major Investor; provided, however, that the
Company shall not be obligated under Section 3.1 or this Section 3.2 to provide information that it deems in good faith to be a trade secret or similar confidential or proprietary information. 

(b) Anything in this Agreement to the contrary notwithstanding, and unless otherwise agreed upon by the Company, the Company shall not be
required to comply with any information rights of 3.1 or 3.2 in respect of any Investor whom the Company reasonably determines to be a competitor or an officer, employee, director or holder of more than ten percent (10%) of a competitor (excluding
an Investor that is an institutional investor that holds ten percent (10%) or more of a competitor as a passive investment). Each Investor acknowledges that the information received by them pursuant to this Agreement is confidential and for its use
only, and it will not use such confidential information in violation of the 1934 Act or reproduce, disclose or disseminate such information to any other person (other than its employees or agents of the Investor having a need to know the contents of
such information, and its attorneys), except in connection with the exercise of rights under this Agreement, unless the Company has made such information available to the public generally. 

(c) For so long as Fidelity Management & Research Company (“Fidelity”) or any of its affiliates or Putnam
Investments (“Putnam”) or any of its affiliates remain a Major Investor, the Company shall give to Fidelity and/or Putnam (as applicable) copies of all notices, minutes, consents and other materials, financial or otherwise, which
the Company provides to its Board; provided, however, that 

  
 11. 

 
the Company reserves the right to exclude Fidelity and/or Putnam (as applicable) from access to any material or portion thereof if the Company believes upon advice of counsel that such exclusion
is reasonably necessary to preserve the attorney-client privilege, to protect highly confidential information and/or to protect highly sensitive information. The decision of the Board with respect to the privileged, confidential and/or sensitive
nature of such information shall be final and binding. 
 3.3 Option/Common Stock Vesting. Unless otherwise approved by the Board or
the Compensation Committee of the Board, the Company hereby covenants that all stock, stock equivalents and options issued after the date hereof to employees, directors, and other service providers of the Company shall vest in accordance with the
following vesting schedule: twenty-five percent (25%) of the shares to vest at the expiration of one (1) year from (a) the date of the grant if the grantee is then in the service of the Company, or (b) the date service commences if
the grantee is not then in service of the Company and the remaining seventy-five percent (75%) of the shares to vest in a series of thirty-six (36) successive and equal monthly installments thereafter
upon the completion by the employee, director, consultant or service provider of each month of service to the Company. Unless otherwise approved by the Board or the Compensation Committee of the Board of the Directors, the Company’s repurchase
option shall provide that upon termination of the service of the employee, director, consultant or other service provider, with or without cause, the Company or its assignee (to the extent permissible under applicable securities laws) retains the
option to repurchase at cost any unvested shares held by such stockholder. 
 3.4 Right of First Offer. Subject to the terms and
conditions specified in this Section 3.4, the Company hereby grants to each Major Investor a right of first offer with respect to future sales by the Company of its Shares (as hereinafter defined). A Major Investor (other than BlackRock) shall
be entitled to apportion the right of first offer hereby granted it among itself and its partners and affiliates in such proportions as it deems appropriate. BlackRock shall be entitled to apportion the rights of first offer hereby granted it among
itself, its partners and affiliates and any other holders of the BlackRock Warrants (or any partners or affiliates of such holders) in such proportions as it deems appropriate. Each time the Company proposes to offer any shares of, or securities
convertible into, exchangeable or exercisable for any shares of, any class or series of its capital stock (“Shares”), the Company shall first make an offering of such Shares to each Major Investor in accordance with the following
provisions: 
 (a) The Company shall deliver a notice (“Notice”) to the Major Investors stating (i) its bona fide
intention to offer such Shares; (ii) the number of such Shares to be offered; and (iii) the price and terms, if any, upon which it proposes to offer such Shares. 

(b) Within ten (10) business days after giving of the Notice, each Major Investor may elect to purchase or obtain, at the price and on
the terms specified in the Notice, up to that portion of such Shares that equals the proportion that the number of shares of Common Stock issued and held, or issuable upon conversion or exercise of the Registrable Securities then held, by such Major
Investor (assuming full conversion and exercise of all convertible and exercisable securities of the Company beneficially owned by such Major Investor) bears to the total number of shares of Common Stock of the Company then outstanding (assuming
full conversion and exercise of all then outstanding convertible and exercisable securities of the Company) (such Major Investor’s “Pro Rata Share”); provided, however, that (x) BlackRock may only purchase up
to that percentage of its Pro Rata Share that is equal to the highest percentage that any other Major Investor elects to purchase of such Major Investor’s Pro Rata Share and (y) for purposes of this Section 3.4, BlackRock shall be
deemed to beneficially own and hold all of the outstanding BlackRock Warrants and all of the outstanding shares of Common Stock originally issued upon exercise of the Blackrock Warrants. The Company shall promptly, in writing, inform each Major
Investor that purchases all the shares available to it (“Fully Exercising Investor”) of any other Major Investor’s failure to do likewise. During the five (5) business day period commencing after such information is given,
each Fully Exercising Investor shall be entitled to purchase up to that portion of the Shares not subscribed for by the Major Investors that is equal to the proportion that the number of shares of Common Stock issued and held, or issuable upon
conversion of Registrable Securities, then held by such Fully Exercising Investor bears to the total number of shares of Common Stock issued and held, or issuable upon conversion of the Registrable Securities then held, by all Fully Exercising
Investors who wish to purchase some of the unsubscribed shares. 

  
 12. 

 (c) If all Shares that Major Investors are entitled to obtain pursuant to subsection 3.4(b) are
not elected to be purchased as provided in subsection 3.4(b) below, the Company may, during the ninety (90) day period following the expiration of the period provided in subsection 3.4(b) below, offer the remaining unsubscribed portion of such
Shares to the following individuals in the following order: (i) to the Common Holders; (ii) the Company Management; and (iii) to any person or persons at a price not less than, and upon terms no more favorable to the offeree than
those specified in the Notice. If the Company does not consummate the sale of the Shares within such period, or if such agreement is not consummated within forty-five (45) days of the execution thereof, the right of first refusal provided
hereunder to the Major Investors shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major Investors in accordance herewith. 

(d) The right of first offer in this Section 3.4 shall not be applicable to (i) shares of Common Stock issued or issuable upon the
conversion of the Preferred Stock or as a dividend or distribution on the Preferred Stock; (ii) shares of capital stock issued or issuable upon exercise of (x) any evidences of indebtedness, shares or other securities directly or
indirectly convertible into or exchangeable for Common Stock (“Convertible Securities”), or (y) options, warrants or other rights to subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities
(“Options”), that are issued and outstanding as of the date hereof; (iii) shares of capital stock issued pursuant to the Company’s bona fide acquisition of another corporation or entity by way of merger, purchase of all or
substantially all of the assets of the corporation, stock for stock exchange or other reorganization or recapitalization approved by the Board and by the holders of a majority of the then-outstanding Preferred Stock, voting together as a class on an
as-converted to common stock basis (the “Requisite Holders”); (iv) shares of Common Stock, and/or Options or Convertible Securities and the Common Stock issued pursuant to such Options or
Convertible Securities after the date hereof to employees, officers or directors of, or consultants or advisors to, the Company or any subsidiary pursuant to stock purchase or stock option plans or other arrangements that are approved by the
Required Board Percentage (as defined in the Company’s Certificate of Incorporation); (v) shares of Common Stock issued upon the closing of a firm commitment underwritten public offering of the Company’s securities pursuant to the
Securities Act, in which all the shares are converted to Common Stock, pursuant to a public offering; (vi) shares of Common Stock issued or issuable by reason of a dividend, stock split, split-up or other
distribution on shares of Common Stock or on securities convertible thereto; (vii) shares of capital stock, warrants or other securities or rights issued to persons or entities with which the Company has entered into or intends to enter into
business relationships, provided such issuances are approved by the Required Board Percentage and are for other than primarily equity financing purposes; or (viii) the BlackRock Warrants and the shares of Common Stock or Preferred Stock
issuable upon exercise thereof or upon conversion of any Preferred Stock issued upon exercise thereof. 
 (e) The right of first offer set
forth in this Section 3.4 may not be assigned or transferred, except that (i) such right is assignable by each Major Investor to any wholly owned subsidiary or parent of, or to any corporation or entity that is, within the meaning of the
Act, controlling, controlled by or under common control with, any such Major Investor, and (ii) such right is assignable between and among any of the Major Investors or between and among any such Investor and any affiliated partnerships,
partners, retired or former partners, members, former members, stockholders, venture capital funds or other entities of such Investor. 

(f) The right of first offer set forth in this Section 3.4 may be amended or waived, in whole or in part, and either prospectively or
retrospectively, only upon the consent of (i) the Company, and (ii) Major Investors holding a majority of all Registrable Securities then held by all the Major Investors (on an as converted to common stock basis). 

3.5 Proprietary Information Agreements. The Company shall require each employee hired by the Company to execute a Proprietary
Information and Inventions Agreement and each consultant or contractor engaged by the Company to execute a Consulting Agreement, each in a form as recommended by the Company’s legal counsel. 

  
 13. 

 3.6 Assignment of Information and Inspection Rights. The information rights set forth in
Section 3.1 and inspection rights in Section 3.2 may be assigned (but only with all related obligations) by a Major Investor, to a transferee or assignee of such securities that (a) is a partner or retired or former partner of any
Major Investor, as applicable, which is a partnership (or partnership under common control); (b) is a Major Investor’s, family member or trust for the benefit of an individual Holder; (c) is a member or former member of any Major Investor,
which is a limited liability company; (d) will hold at least one million eight hundred thousand (1,800,000) shares of Registrable Securities (as adjusted for dividends, splits, recapitalizations and the like); or (e) to any wholly-owned
subsidiary or parent of, or to any corporation or entity that is, within the meaning of the Act, controlling, controlled by or under common control with, any such Major Investor. 

3.7 Assignment of Right of First Refusal. In the event the Company elects not to exercise any right of first refusal or right of first
offer the Company may have on a proposed transfer of any of the Company’s outstanding capital stock pursuant to the Company’s charter documents, by contract or otherwise, the Company shall, to the extent it may do so, assign such right of
first offer to each Major Investor. In the event of such assignment, each Major Investor shall have a right to purchase its pro rata portion of the capital stock proposed to be transferred. Each Major Investor’s pro rata portion shall be equal
to the product obtained by multiplying (i) the aggregate number of shares proposed to be transferred, by (ii) a fraction, the numerator of which is the number of shares of Registrable Securities held by such Major Investor at the time of
the proposed transfer and the denominator of which is the total number of Registrable Securities owned by all Major Investors at the time of such proposed transfer. 

3.8 Reimbursement of Directors and Advisors. The Company shall reimburse the Board for all reasonable costs incurred in attending
meetings of the Board and meetings or events attended upon the request of the Company. 
 3.9 Compensation Committee. Unless otherwise
approved by the Board, the Compensation Committee of the Board shall implement salary and equity guidelines for the Company, as well as approve compensation packages, severance agreements and employment for all senior management, including offers
above one hundred eighty thousand dollars ($180,000) and equity packages above one half percent (0.5%) of the Company on a fully-diluted basis. The Compensation Committee shall at all times consist of at least two (2) members, and all members
shall be non-employee Directors of the Company. 
 3.10 At Will Employment. Unless otherwise
approved by the Board, all employees employed by the Company shall be “at will.” 
 3.11 D&O Insurance. The Company
shall maintain director and officer liability insurance from a nationally recognized insurer with a coverage amount of at least $5,000,000. 

3.12 Future Issuance of Series H Preferred Stock. Any issuance of Series H Preferred Stock in excess of the amounts authorized to be
sold under the Series H Agreement must be approved by the Board. 
 3.13 Termination of Covenants. The covenants set forth in this
Section 3 shall terminate as to Investors and be of no further force or effect upon the earlier to occur of (a) the consummation of a firm commitment underwritten public offering of the Company’s securities pursuant to which all
outstanding shares of Preferred Stock convert into Common Stock, or (b) the consummation of a Liquidation Event (as defined in the Company’s Certificate of Incorporation). With respect to Sections 3.1 and 3.2, unless earlier terminated
pursuant to the previous sentence, such provisions shall terminate when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or Section 15(d) of the 1934 Act. 

4. Miscellaneous. 
 4.1
Successors and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any
shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or
by reason of this Agreement, except as expressly provided in this Agreement. 

  
 14. 

 4.2 Governing Law. This Agreement shall be governed by and construed under the laws of the
State of California without regard for conflicts of laws principles. 
 4.3 Counterparts. This Agreement may be executed in two or
more counterparts, including counterparts transmitted by facsimile, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

4.4 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement. 
 4.5 Notices. All notices required or permitted under this Agreement shall be given in
writing and shall be deemed effectively given: (i) upon personal delivery to the party to be notified; (ii) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient; if not, then on the next
business day; (iii) five (5) days after deposit in the United States mail, by registered or certified mail, postage prepaid and properly addressed to the party to be notified as set forth on the signature page hereof, or at such other address
as such party may designate by ten (10) days’ advance written notice to the other parties hereto; or (iv) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written
verification of receipt. 
 4.6 Attorneys’ Fees. If any dispute among the parties to this Agreement results in litigation, the
prevailing party in such dispute shall be entitled to recover from the losing party all fees, costs and expenses of enforcing any right of such prevailing party under or with respect to this Agreement, including, without limitation, such reasonable
fees and expenses of attorneys and accountants, that shall include, without limitation, all fees, costs and expenses of appeals. 
 4.7
Amendments and Waivers. 
 (a) Any term of this Agreement (other than Sections 2.2, 2.16, 3.1, 3.2, 3.4 and 3.13) may be amended and
the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the holders of a majority of the Registrable
Securities then outstanding (on an as-converted to Common Stock basis). Sections 2.2 and 2.16 may be amended and the observance of any term in such section may be waived (either generally or in a particular
instance and either retroactively or prospectively) with the written consent of the Company and Investors holding a majority of the Registrable Securities then held by all Investors (on an as-converted to
Common Stock basis). Sections 3.1, 3.2 and 3.13 may be amended and the observance of any terms in such sections may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of
the Company and the holders of a majority interest of the Major Investors based on the number of shares of Registrable Securities then held by the Major Investors (on an as-converted to Common Stock basis).
Section 3.4 may be amended and the observance of any terms in such sections may be waived (either generally or in a particular instance and either retroactively or prospectively) only as provided in Section 3.4(f). 

(b) Any amendment or waiver effected in accordance with this section shall be binding upon each holder of any Registrable Securities then
outstanding, each future holder of all such Registrable Securities and the Company. 
 (c) Notwithstanding anything to the contrary
contained herein: 
 (i) the amendment of this Agreement to include additional parties as Investors or Common Holders, or additional shares
as Registrable Securities, whether pursuant to the Series H Agreement or any future transaction or agreement, shall not require the separate consent of the Common Holders; 

  
 15. 

 (ii) the Company may amend this Agreement solely to add a party who after the date of this
Agreement acquires shares of the Company’s Series H Preferred Stock pursuant to the terms of the Series H Agreement; 
 (iii) if any
waiver or amendment of any term of this Agreement has the effect of affecting either BlackRock or Hercules (i) in a manner different than the other Investors and (ii) in a manner adverse to the interests of BlackRock or Hercules,
respectively, then such amendment shall require the prior written consent of BlackRock or Hercules, respectively; provided, that no waiver or amendment of Sections 3.1 or 3.2 or this sentence shall be effective as to BlackRock or Hercules
without its prior written consent; and 
 (iv) if any waiver or amendment of any term of this Agreement affects the Series H Investors in an
adverse manner different than the other Investors, then such waiver or amendment shall require the prior written consent of a majority of the shares of Series H Preferred Stock; provided, that no waiver or amendment of Sections 2.14, 3.1 or 3.2 or
this sentence shall be effective as to any Series H Investor that is a registered investment company under the Investment Company Act of 1940, as amended, without such investor’s prior written consent. 

(d) Any additional party to the Agreement allowed by this section shall, by executing a counterpart signature page to this Agreement, become
an Investor or Common Holder, as applicable, for all purposes and shall be bound by all of the applicable provisions under this Agreement. 

4.8 Severability. If any of the provisions of this Agreement should, for any reason, be held by a court or other tribunal of competent
jurisdiction to be illegal, invalid or unenforceable in any respect, such provisions shall be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full force and effect. 

4.9 Aggregation of Stock. All shares of Registrable Securities held or acquired by affiliated entities or persons shall be aggregated
together for the purpose of determining the availability of any rights under this Agreement. 
 4.10 Entire Agreement. This Agreement
constitutes the full and entire understanding and agreement among the parties with regard to the subjects hereof. 
 4.11 Facsimile.
This Agreement may be executed via facsimile. 
 [Remainder of page intentionally left blank] 

  
 16. 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	COMPANY:
	
	OPORTUN FINANCIAL CORPORATION
		
	By:	 	 /s/ Raul Vazquez

	Name:	 	Raul Vazquez
	Title:	 	Chief Executive Officer
		
	Address:	 	1600 Seaport Boulevard, Suite 250
		 	Redwood City, CA 94063

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	PYRAMIS LIFECYCLE BLUE CHIP GROWTH
	COMMINGLED POOL
		
	By:	 	Pyramis Global Advisors Trust Company, as Trustee
		
	By:	 	 /s/ Douglas Payne

	Name:	 	Douglas Payne
	Title:	 	V.P. Treasury
	
	FIDELITY SECURITIES FUND: FIDELITY BLUE CHIP GROWTH FUND
		
	By:	 	 /s/ Stacie M. Smith

	Name:	 	Stacie M. Smith
	Title:	 	Authorized Signatory
	
	FIDELITY SECURITIES FUND: FIDELITY SERIES BLUE CHIP GROWTH FUND
		
	By:	 	 /s/ Stacie M. Smith

	Name:	 	Stacie M. Smith
	Title:	 	Authorized Signatory

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	FIDELITY CONTRAFUND: FIDELITY ADVISOR SERIES OPPORTUNISTIC INSIGHTS FUND
		
	By:	 	 /s/ Stacie M. Smith

	Name:	 	 Stacie M. Smith

	Title:	 	 Authorized Signatory

	
	FIDELITY CONTRAFUND: FIDELITY SERIES OPPORTUNISTIC INSIGHTS FUND
		
	By:	 	 /s/ Stacie M. Smith

	Name:	 	Stacie M. Smith
	Title:	 	Authorized Signatory
	
	FIDELITY CONTRAFUND: FIDELITY ADVISOR NEW INSIGHTS FUND
		
	By:	 	 /s/ Stacie M. Smith

	Name:	 	Stacie M. Smith
	Title:	 	Authorized Signatory

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	Each of the entities listed on Annex A hereto
		
	By:	 	Putnam Investment Management, LLC
		
	By:	 	 /s/ Aaron M. Cooper

	Name:	 	Aaron M. Cooper
	Title:	 	Director of Global Equity Research

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 Annex A 

Putnam Voyager Fund* 
 Putnam Variable Trust - Putnam VT Voyager
Fund* 
 Putnam Variable Trust - Putnam VT Multi-Cap Growth Fund* 

The George Putnam Fund of Boston* 
 Putnam Equity Income Fund*

 Putnam Multi-Cap Growth Fund* 

Putnam Variable Trust - Putnam VT Equity Income Fund* 
 Putnam
Variable Trust - Putnam VT The George Putnam Fund of Boston* 
 Putnam Variable Trust - Putnam VT Research Fund* 

Putnam Investment Funds - Putnam Research Fund* 
 Great-West
Funds, Inc. - Great-West Putnam Equity Income Fund 
 Putnam Global Financials Fund* 

A copy of the Agreement and Declaration of Trust of each above Investor indicated with an “*” is on file with the Secretary of The Commonwealth of
Massachusetts, and notice is hereby given that the Agreement is executed on behalf of the trustees of Investor as trustees and not individually and that any obligations of or arising out of the Agreement are not binding on any of the trustees,
officers or shareholders individually of Investor, but are binding only upon the trust property of Investor. Furthermore, notice is given that the trust property of any series of the series trust applicable to Investor, if applicable, is separate
and distinct and that any obligations of or arising out of the Agreement are several and not joint or joint and several and are binding only on the trust property of Investor with respect to its obligations under the Agreement. 

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	Each of the entities listed on Annex B hereto
	
	By: The Putnam Advisory Company, LLC
		
	By:	 	 /s/ Aaron M. Cooper

	Name:	 	Aaron M. Cooper
	Title:	 	Director of Global Equity Research

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 Annex B 

The International Investment Fund - Putnam U.S. Research Equity Fund 

SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	INSTITUTIONAL VENTURE PARTNERS XIV, L.P.
		
	By:	 	Institutional Venture Management XIV LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Jules Maltz

 
			
		
	Address:	 	3000 Sand Hill Road
		 	Building 2, Suite 250
		 	Menlo Park, CA 94025

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	HERCULES TECHNOLOGY GROWTH CAPITAL INC.
		
	By:	 	 /s/ Christine Fera

	Name:	 	Christine Fera
	Title:	 	Director of Contract

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	GREYLOCK XII LIMITED PARTNERSHIP
	By: Greylock XII GP LLC, its General Partner

 
			
		
	By:	 	 /s/ Donald A. Sullivan

			
	Name:	 	Donald A. Sullivan
	Title:	 	Administrative Partner
	
	GREYLOCK XII-A LIMITED PARTNERSHIP
	By: Greylock XII GP LLC, its General Partner

 
			
		
	By:	 	 /s/ Donald A. Sullivan

			
	Name:	 	Donald A. Sullivan
	Title:	 	Administrative Partner
	
	GREYLOCK XII PRINCIPALS LLC
	By: Greylock Management Corporation, Sole Member

 
			
		
	By:	 	 /s/ Donald A. Sullivan

			
	Name:	 	Donald A. Sullivan
	Title:	 	Treasurer

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Investors’ Rights
Agreement as of the date first above written. 
  

			
	
	INVESTOR:
	
	 MADRONE PARTNERS, L.P.
 by
its General Partner, Madrone Capital Partners, LLC

 
			
		
	By:	 	 /s/ Thomas Patterson

			
	Name:	 	Thomas Patterson
	Title:	 	Managing Director

 SIGNATURE PAGE TO AMENDED AND RESTATED 

INVESTORS’ RIGHTS AGREEMENT 

 SCHEDULE A 

COMMON HOLDERS 
 James Gutierrez 

Andres Nannetti as Trustee of Gutierrez Family 2009 Irrevocable Trust 

The James Gutierrez 2009 Grantor Retained Annuity Trust 
 James
Gutierrez as Trustee of James Gutierrez 2010 Grantor Retained Annuity Trust 
 Katja Bjorner 

Raymond Dunkerey 
 Monica Gutierrez 

Ramona Gutierrez 
 James Gutierrez as Trustee for Anna Bernadi
UTMA until Age 21 
 James Gutierrez as Trustee for Annabella Dunkerley UTMA until Age 21 

James Gutierrez as Trustee for Arthur Bernadi UTMA until Age 21 

James Gutierrez as Trustee for Onnika Dunkerley UTMA until Age 21 

Haydee Karz 

 SCHEDULE B 

SERIES A-1 INVESTORS 

Wood Ventures LLC 
 Pedro Urquidi 

Michael A. Torres, Trustee for CT2G Irrevocable Trust 
 Michael A.
Torres, Trustee for CT3G Irrevocable Trust 
 Gregg Young, Trustee for Young Living Trust 

JCP Family LP 
 Kerrigan Capital LLC 

Great Oaks Ventures LLC 
 Jeffrey T. Chambers and Andrea Okamure
Trust Dated 9/13/99 
 Gregorio Schneider 
 The Francisco Trust

 Robert A. Seaver 
 Jose A. Briones, Jr. 

Chris Larsen 
 Goodwin Procter LLP 

 SCHEDULE C 

SERIES B-1 INVESTORS 

Greylock XII Limited Partnership 
 Greylock XII-A Limited Partnership 
 Greylock XII Principals LLC 

Mapache Investment LP, Fund V 
 Monkey Ventures 

Elie Seidman 
 Lars Dalgaard 

Tom Dailey 
 Serendipity Investments S.L. 

Coan Torres Family Trust 
 CT2G Irrevocable Trust 

CT3G Irrevocable Trust 
 TH Media 

Jeffrey T. Chambers and Andrea Okamura Trust Dated 9/13/99 
 Jimmy
Gutierrez 
 Gregorio Schneider 
 The FranciscoTrust 

Robert Seaver 
 Serendipity Investments LP 

Wood Ventures LLC 
 Paul Sallabery 

Channing Bosler 
 FG Capital, LLC 

 SCHEDULE D 

SERIES C-1 INVESTORS 

Charles River Partnership XIII, LP 
 Charles River Friends XIII-A, LP 
 Greylock XII Limited Partnership 

Greylock XII-A Limited Partnership 

Greylock XII Principals LLC 
 Mapache Investment LP, Fund V 

Michael A. Torres, Trustee for CT2G Irrevocable Trust 
 Michael A.
Torres, Trustee for CT3G Irrevocable Trust 
 Michael A. Torres, Trustee for The Coan Torres Family Trust 

TH Holdings (Scott Wood) 
 James and Maria Jones Trust 

Gregorio Schneider 
 Jimmy L. Gutierrez 

Serendipity Investment LP (Jose Marin) 
 Channing Bosler 

David Razavi 
 Nicolas Bernadi 

John LeClaire 
 The CFSI Catalyst Fund, L.P. 

Emily Wood Melton 
 Leslie Family Trust U/A 2/7/96 

Paradise & Palm Investments, LLC 
 Madrone Partners, LLC

 GC&H Investments, LLC 
 Jeffrey T. Chambers and Andrea
Okamura Trust Dated 9/13/99 
 Adam Rodriguez Living Trust Dated January 9, 2007 

 SCHEDULE E 

SERIES D-1 INVESTORS 

Madrone Partners, L.P. 
 Greylock XII Limited Partnership 

Greylock XII-A Limited Partnership 

Greylock XII Principals LLC 
 Charles River Partnership XIII, LP

 Charles River Friends XIII-A, LP 

TPG Progress, L.P. 
 DAG Ventures
IV-QP, L.P. 
 DAG Ventures IV, L.P 

Adam Rodriguez Living Trust Dated January 9, 2007 

Paradise & Palm Investments, LLC 
 GC&H Investments,
LLC 
 John LeClaire 

 SCHEDULE F 

SERIES E-1 INVESTORS 

Greylock XII Limited Partnership 
 Greylock XII-A Limited Partnership 
 Greylock XII Principals LLC 

Madrone Partners, L.P. 
 Mapache Investment LP, Fund V 

TPG Progress, L.P. 
 DAG Ventures
IV-QP, L.P. 
 DAG Ventures IV, L.P 

Paradise & Palm Investments, LLC 
 SVB Capital Partners
II, L.P. 
 SVB Financial Group 

 SCHEDULE G 

SERIES F INVESTORS 
 Greylock XII Limited
Partnership 
 Greylock XII-A Limited Partnership 

Greylock XII Principals LLC 
 Madrone Partners, L.P. 

Mapache Investment LP, Fund V 
 Charles River Partnership XIV, LP

 Charles River Friends XIV-A, LP 

TPG Progress, L.P. 
 DAG Ventures
IV-QP, L.P. 
 DAG Ventures IV, L.P. 

Paradise & Palm Investments, LLC 
 Adam Rodriguez Living
Trust Dated January 9, 2007 
 Glynn Partners II, L.P. 

SVB Capital Partners II, L.P. 
 SVB Financial Group 

GC&H Investments, LLC 
 Emily Melton 

Navid Razavi 
 Pedro Urquidi 

Jose A. Briones, Jr. 
 Peterson Ventures III, LLC 

James and Maria Jones Trust, Dated 4/30/1990 
 Leslie Family Trust
U/A 2/7/96 
 Sallaberry Family Trust 
 Jimmy Gutierrez 

Serendipity Investments S.L. 

 SCHEDULE H 

SERIES F-1 INVESTORS 

Greylock XII Limited Partnership 
 Greylock XII-A Limited Partnership 
 Greylock XII Principals LLC 

Madrone Partners, L.P. 
 Mapache Investment LP, Fund V 

DAG Ventures IV-QP, L.P. 

DAG Ventures IV, L.P. 
 Glynn Partners II, L.P. 

Paradise & Palm Investments, LLC 
 Jose A. Briones, Jr.

 GC&H Investments, LLC 
 James and Maria Jones Trust,
Dated 4/30/1990 
 BlackRock Kelso Capital Corporation 
 Core
Innovation Capital I, L.P. 
 Michael A. Torres, Trustee for The Coan Torres Family Trust 

Gregorio Schneider 

 SCHEDULE I 

SERIES G INVESTORS 
 Institutional Venture
Partners XIV, L.P. 
 Glynn Partners II, L.P. 
 Glynn Partners
III, L.P. 
 Madrone Partners, L.P. 
 Greylock XII Limited
Partnership 
 Greylock XII-A Limited Partnership 

Greylock XII Principals LLC 
 Mapache Investment LP, Fund V 

Core Innovation Capital I, L.P. 
 Castro-Wright Living Trust 

BlackRock Kelso Capital Corporation 
 SVB Capital Partners II,
L.P. 
 Hercules Technology Growth Capital, Inc. 

Paradise & Palm Investments, LLC 
 TPG Progress, L.P.

 SCHEDULE J 

SERIES H INVESTORS 
 Pyramis Lifecycle
Blue Chip Growth Commingled Pool 
 Fidelity Securities Fund: Fidelity Blue Chip Growth Fund 

Fidelity Securities Fund: Fidelity Series Blue Chip Growth Fund 

Fidelity Contrafund: Fidelity Advisor Series Opportunistic Insights Fund 

Fidelity Contrafund: Fidelity Series Opportunistic Insights Fund 

Fidelity Contrafund: Fidelity Advisor New Insights Fund 
 Putnam
Voyager Fund 
 Putnam Variable Trust—Putnam VT Voyager Fund 

Putnam Variable Trust—Putnam VT Multi-Cap Growth Fund 

The George Putnam Fund of Boston 
 Putnam Equity Income Fund 

Putnam Multi-Cap Growth Fund 

Putnam Variable Trust—Putnam VT Equity Income Fund 
 Putnam
Variable Trust—Putnam VT The George Putnam Fund of Boston 
 Putnam Variable Trust—Putnam VT Research Fund 

Putnam Investment Funds—Putnam Research Fund 
 Great-West
Funds, Inc.—Great-West Putnam Equity Income Fund 
 Putnam Global Financials Fund 

The International Investment Fund—Putnam U.S. Research Equity Fund 

Institutional Venture Partners XIV, L.P. 
 Hercules Technology
Growth Capital Inc.EX-4.3

 Exhibit 4.3 

THIS WARRANT, AND THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”), OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL) REASONABLY
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT, OR ANY APPLICABLE STATE SECURITIES LAWS. 
 WARRANT
AGREEMENT 
 To Purchase Shares of Preferred Stock of 

PROGRESO FINANCIERO HOLDINGS, INC. 

Dated as of [                ] (the “Effective
Date”) 
 WHEREAS, the Company (as defined below), has caused its wholly owned subsidiary, PROGRESS FINANCIAL CORPORATION, a Delaware corporation,
to entered into a Loan and Security Agreement of even date herewith (the “Loan Agreement”) with Hercules Technology Growth Capital, Inc., a Maryland corporation (the “Warrantholder”); 

WHEREAS, the Company desires to grant to Warrantholder, in consideration for, among other things, the financial accommodations provided for in the Loan
Agreement, the right to purchase shares of Preferred Stock (as defined below) pursuant to this Warrant Agreement (the “Agreement”); 
 NOW,
THEREFORE, in consideration of the Warrantholder executing and delivering the Loan Agreement and providing the financial accommodations contemplated therein, and in consideration of the mutual covenants and agreements contained herein, the Company
and Warrantholder agree as follows: 
 SECTION 1.    GRANT OF THE RIGHT TO PURCHASE PREFERRED STOCK. 

For value received, the Company hereby grants to the Warrantholder, and the Warrantholder is entitled, upon the terms and subject to the conditions hereinafter
set forth, to subscribe for and purchase, from the Company, an aggregate number of fully paid and non-assessable shares of the Preferred Stock equal to the quotient derived by dividing (a)
[$                ] by (b) the Exercise Price (defined below). As used herein, the following terms shall have the following meanings: 

“Act” means the Securities Act of 1933, as amended. 

“Company” means PROGRESO FINANCIERO HOLDINGS, INC., a Delaware corporation, and any successor or surviving entity that assumes
the obligations of the Company under this Agreement pursuant to Section 8(a). 
 “Charter” means the Company’s
Articles of Incorporation, Certificate of Incorporation or other constitutional document, as may be amended from time to time. 

“Common Stock” means the Company’s common stock, $0.0001 par value per share; 

“Equity Round” means any non-public offering of equity securities by the Company,
after the Effective Date but prior to the consummation of an Initial Public Offering, in a transaction or series of related transactions principally for equity financing purposes in which the cash is received by the Company and/or debt of the
Company is cancelled or converted in exchange for equity securities of the Company. 
 “Exercise Price” means (a) if
Preferred Stock (as defined below) means Series F-1 Preferred Stock, then the Exercise Price shall be $0.768191 per share, or (b) if Preferred Stock means Next Round Stock (as defined below), then the
Exercise Price shall be a price equal to (i) the price per share of Next Round Stock paid by investors in the Next Round (the “Next Round Price”) less (ii) a discount equal to 15% of the absolute difference between the price per
share, $0.768191, paid for the Series F-1 Preferred Stock and the Next Round Price paid by investors in the Next Round, in each case subject to adjustment pursuant to Section 8. 

  
 1 

 “Initial Public Offering” means the initial underwritten public offering of the
Company’s Common Stock pursuant to a registration statement under the Act, which public offering has been declared effective by the Securities and Exchange Commission (“SEC”); 

“Merger Event” means any sale, lease or other transfer of all or substantially all assets of the Company or any merger or
consolidation involving the Company in which the Company is not the surviving entity, or in which the outstanding shares of the Company’s capital stock are otherwise converted into or exchanged for shares of preferred stock, other securities or
property of another entity; 
 “Next Round” means the next Equity Round in which the Company issues and sells shares of its
preferred stock for aggregate gross cash proceeds of at least $17,000,000 which amount shall include $7,000,000 in notes which contain a mandatory conversion provision requiring the notes to be convertible into common stock in such Next Round; 

“Preferred Stock” means, (A) the class and series of the preferred stock of the Company issued in the Next Round (such
stock, the “Next Round Stock”), which closes on or before December 31, 2013 or (B) if the closing of the Next Round does not occur on or prior to December 31, 2013, the Series
F-1 Preferred Stock of the Company, and, to the extent provided in Sections 8(a) and (b), any other stock into or for which such Preferred Stock may be converted or exchanged; provided that upon and after the
occurrence of an event which results in the automatic or voluntary conversion, redemption or retirement of all (but not less than all) of the outstanding shares of such Preferred Stock, including, without limitation, the consummation of an Initial
Public Offering of the Common Stock in which such a conversion occurs, then from and after the date upon which such outstanding shares are so converted, redeemed or retired, “Preferred Stock” shall mean the Common Stock; and 

“Purchase Price” means, with respect to any exercise of this Agreement, an amount equal to the Exercise Price as of the
relevant time multiplied by the number of shares of Preferred Stock requested to be exercised under this Agreement pursuant to such exercise. 

SECTION 2.    TERM OF THE AGREEMENT. 

Except as otherwise provided for herein, the term of this Agreement and the right to purchase Preferred Stock as granted herein (the “Warrant) shall
commence on the Effective Date and shall be exercisable for a period ending upon the earlier to occur of (i) seven (7) years from the Effective Date; or (ii) three (3) years after the Initial Public Offering. 

SECTION 3.    EXERCISE OF THE PURCHASE RIGHTS. 

(a)    Exercise. The purchase rights set forth in this Agreement are exercisable by the Warrantholder, in whole or
in part, at any time, or from time to time, prior to the expiration of the term set forth in Section 2, by tendering to the Company at its principal office a notice of exercise in the form attached hereto as Exhibit I (the
“Notice of Exercise”), duly completed and executed. Promptly upon receipt of the Notice of Exercise and the payment of the Purchase Price in accordance with the terms set forth below, and in no event later than three (3) days
thereafter, the Company shall issue to the Warrantholder a certificate for the number of shares of Preferred Stock purchased and shall execute the acknowledgment of exercise in the form attached hereto as Exhibit II (the
“Acknowledgment of Exercise”) indicating the number of shares which remain subject to future purchases, if any. 

  
 2 

 The Purchase Price may be paid at the Warrantholder’s election either (i) by cash or check, or
(ii) by surrender of all or a portion of the Warrant for shares of Preferred Stock to be exercised under this Agreement and, if applicable, an amended Agreement representing the remaining number of shares purchasable hereunder, as determined
below (“Net Issuance”). If the Warrantholder elects the Net Issuance method, the Company will issue Preferred Stock in accordance with the following formula: 
  

					
		 		 	 X = Y(A-B)

		 		 	
              A

			
	Where:	 	X =	 	the number of shares of Preferred Stock to be issued to the Warrantholder.
			
		 	Y =	 	the number of shares of Preferred Stock requested to be exercised under this Agreement.
			
		 	A =	 	the fair market value of one (1) share of Preferred Stock at the time of issuance of such shares of Preferred Stock.
			
		 	B =	 	the Exercise Price.

 For purposes of the above calculation, current fair market value of Preferred Stock shall mean with respect to each share of
Preferred Stock: 
 (i)    if the exercise is in connection with an Initial Public Offering, and if the Company’s
Registration Statement relating to such Initial Public Offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public” of the Common Stock specified in
the final prospectus with respect to the offering and (y) the number of shares of Common Stock into which each share of Preferred Stock is convertible at the time of such exercise; 

(ii)    if the exercise is after, and not in connection with an Initial Public Offering, and: 

(A)    if the Common Stock is traded on a securities exchange, the fair market value shall be deemed to be the product of
(x) the prior day closing price before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Preferred Stock is convertible at the time of such
exercise; or 
 (B)    if the Common Stock is traded
over-the-counter, the fair market value shall be deemed to be the product of (x) the prior day closing bid and asked price quoted on the NASDAQ system (or similar
system) before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Preferred Stock is convertible at the time of such exercise; 

(iii)    if at any time the Common Stock is not listed on any securities exchange or quoted in the NASDAQ National Market
or the over-the-counter market, the current fair market value of Preferred Stock shall be the product of (x) the highest price per share which the Company could
obtain from a willing buyer (not a current employee or director) for shares of Common Stock sold by the Company, from authorized but unissued shares, as determined in good faith by its Board of Directors and (y) the number of shares of Common
Stock into which each share of Preferred Stock is convertible at the time of such exercise, unless the Company shall become subject to a Merger Event, in which case the fair market value of Preferred Stock shall be deemed to be the per share value
received by the holders of the Company’s Preferred Stock on a common equivalent basis pursuant to such Merger Event. 
 Upon partial exercise by either
cash or Net Issuance, the Company shall promptly issue an amended Agreement representing the remaining number of shares purchasable hereunder. All other terms and conditions of such amended Agreement shall be identical to those contained herein,
including, but not limited to the Effective Date hereof. 
 (b)    Exercise Prior to Expiration. To the extent
this Agreement is not previously exercised as to all Preferred Stock subject hereto, and if the fair market value of one share of the Preferred Stock is greater than the Exercise Price then in effect, this Agreement shall be deemed automatically
exercised pursuant to Section 3(a) (even if not surrendered) immediately before its expiration. For purposes of such automatic exercise, the fair market value of one share of the Preferred Stock upon such expiration shall be determined pursuant
to Section 3(a). To the extent this Agreement or any portion thereof is deemed automatically exercised pursuant to this Section 3(b), the Company agrees to promptly notify the Warrantholder of the number of shares of Preferred Stock, if
any, the Warrantholder is to receive by reason of such automatic exercise. 

  
 3 

 SECTION 4.    RESERVATION OF SHARES. 

During the term of this Agreement, the Company will at all times have authorized and reserved a sufficient number of shares of its Preferred Stock to provide
for the exercise of the rights to purchase Preferred Stock as provided for herein, and shall have authorized and reserved a sufficient number of shares of its Common Stock to provide for the conversion of the Preferred Shares available hereunder.

 SECTION 5.    NO FRACTIONAL SHARES OR SCRIP. 

No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Agreement, but in lieu of such fractional shares the
Company shall make a cash payment therefor upon the basis of the Exercise Price then in effect. 
 SECTION
6.    NO RIGHTS AS SHAREHOLDER/STOCKHOLDER. 
 This Agreement does not entitle the Warrantholder to any voting rights or other rights
as a shareholder/stockholder of the Company prior to the exercise of this Agreement. 
 SECTION
7.    WARRANTHOLDER REGISTRY. 
 The Company shall maintain a registry showing the name and address of the registered holder of this
Agreement. Warrantholder’s initial address, for purposes of such registry, is set forth below Warrantholder’s signature on this Agreement. Warrantholder may change such address by giving written notice of such changed address to the
Company. 
 SECTION 8.    ADJUSTMENT RIGHTS. 

The Exercise Price and the number of shares of Preferred Stock purchasable hereunder are subject to adjustment, as follows: 

(a)    Merger Event. If at any time there shall be Merger Event, then, as a part of such Merger Event, lawful
provision shall be made so that the Warrantholder shall thereafter be entitled to receive, upon exercise of this Agreement, the number of shares of preferred stock or other securities or property (collectively, “Reference Property”)
that the Warrantholder would have received in connection with such Merger Event if Warrantholder had exercised this Agreement immediately prior to the Merger Event. In any such case, appropriate adjustment (as determined in good faith by the
Company’s Board of Directors) shall be made in the application of the provisions of this Agreement with respect to the rights and interests of the Warrantholder after the Merger Event to the end that the provisions of this Agreement (including
adjustments of the Exercise Price and adjustments to ensure that the provisions of this Section 8 shall thereafter be applicable, as nearly as possible, to the purchase rights under this Agreement in relation to any Reference Property
thereafter acquirable upon exercise of such purchase rights) shall continue to be applicable in their entirety, and to the greatest extent possible. Without limiting the foregoing, in connection with any Merger Event, upon the closing thereof, the
successor or surviving entity shall assume the obligations of this Agreement; provided that if the Reference Property includes shares of stock or other securities and assets of an entity other than the successor or purchasing company, as the case
may be, in such Merger Event, then such other entity shall assume the obligations under this Agreement and any such assumption shall contain such additional provisions to protect the interests of the Warrantholder as reasonably necessary by reason
of the foreogoing (as determined in good faith by the Company’s Board of Directors) . In connection with a Merger Event and upon Warrantholder’s written election to the Company, the Company shall cause this Warrant Agreement to be
exchanged for the consideration that Warrantholder would have received if Warrantholder had chosen to exercise its right to have shares issued pursuant to the Net Issuance provisions of this Warrant Agreement without actually exercising such right,
acquiring such shares and exchanging such shares for such consideration. The provisions of this Section 8(a) shall similarly apply to successive Merger Events. 

  
 4 

 (b)      Reclassification of Shares. Except for Merger
Events subject to Section 8(a), and subject to Section 8(f), if the Company at any time shall, by combination, reclassification, exchange or subdivision of securities or otherwise, change any of the securities as to which purchase rights
under this Agreement exist into the same or a different number of securities of any other class or classes, this Agreement shall thereafter represent the right to acquire such number and kind of securities as would have been issuable as the result
of such change with respect to the securities which were subject to the purchase rights under this Agreement immediately prior to such combination, reclassification, exchange, subdivision or other change. The provisions of this Section 8(b)
shall similarly apply to successive combination, reclassification, exchange, subdivision or other change. 

(c)      Subdivision or Combination of Shares. If the Company at any time shall combine or subdivide its
Preferred Stock, (i) in the case of a subdivision, the Exercise Price shall be proportionately decreased, , or (ii) in the case of a combination, the Exercise Price shall be proportionately increased,. 

(d)      Stock Dividends. If the Company at any time while this Agreement is outstanding and unexpired
shall: 
 (i)     pay a dividend with respect to the Preferred Stock payable in Preferred Stock, then the Exercise
Price shall be adjusted, from and after the date of determination of shareholders entitled to receive such dividend or distribution, to that price determined by multiplying the Exercise Price in effect immediately prior to such date of determination
by a fraction (A) the numerator of which shall be the total number of shares of Preferred Stock outstanding immediately prior to such dividend or distribution, and (B) the denominator of which shall be the total number of shares of
Preferred Stock outstanding immediately after such dividend or distribution; or 
 (ii)    make any other distribution
with respect to Preferred Stock (or stock into which the Preferred Stock is convertible), except any distribution specifically provided for in any other clause of this Section 8, then, in each such case, provision shall be made by the Company
such that the Warrantholder shall receive upon exercise or conversion of this Warrant a proportionate share of any such distribution as though it were the holder of the Preferred Stock (or other stock for which the Preferred Stock is convertible) as
of the record date fixed for the determination of the shareholders of the Company entitled to receive such distribution. 

(e)      Antidilution Rights. Additional antidilution rights applicable to the Preferred Stock
purchasable hereunder are as set forth in the Charter and shall be applicable with respect to the Preferred Stock issuable hereunder. The Company shall promptly provide the Warrantholder with any restatement, amendment, modification or waiver of the
Charter; provided, that no such amendment, modification or waiver shall impair or reduce the antidilution rights applicable to the Preferred Stock as of the date hereof unless such amendment, modification or waiver affects the rights of
Warrantholder with respect to the Preferred Stock in the same manner as it affects all other holders of Preferred Stock. The Company shall provide Warrantholder with prior written notice of any issuance of its stock or other equity security to occur
after the Effective Date of this Agreement, which notice shall include (a) the price at which such stock or security is to be sold, (b) the number of shares to be issued, and (c) such other information as necessary for Warrantholder
to determine if a dilutive event has occurred. For the avoidance of doubt, there shall be no duplicate anti-dilution adjustment pursuant to this subsection (e), the forgoing subsection (d) and the Charter. 

(f)      Other Dilutive Events. In case any event shall occur affecting the Company, as to which the
provisions of this Section 8 and the anti-dilution protections in the Charter are not strictly applicable but the failure to make any adjustment would not reasonably and fairly protect the purchase rights represented by this Agreement in
accordance with the intent and principles of this Section 8 and the anti-dilution protections in the Charter then, in each such case, the Company’s Board of Directors shall make an appropriate adjustment in the Exercise Price so as to
protect the rights of the Warrantholder in a manner consistent with the provisions of this Section 8 and the anti-dilution protections of the Charter. 

  
 5 

 Notwithstanding the foregoing, no adjustment pursuant to this Section 8(f) shall increase the Exercise Price
or decrease the number of shares of Preferred Stock issuable upon exercise of the purchase rights under this Agreement as otherwise determined pursuant to this Section 8. 

(g)    Notice of Adjustments. If: (i) the Company shall declare any dividend or distribution upon its stock,
whether in stock, cash, property or other securities, (ii) the Company shall offer for subscription prorata to the holders of any class of its Preferred Stock or other capital stock any additional shares of stock of any class or other rights;
(iii) there shall be any Merger Event; (iv) there shall be an Initial Public Offering; (v) the Company shall sell, lease, license or otherwise transfer all or substantially all of its assets; or (vi) there shall be any voluntary
dissolution, liquidation or winding up of the Company; then, in connection with each such event, the Company shall send to the Warrantholder: (A) at least thirty (30) days’ prior written notice of the date on which the books of the
Company shall close or a record shall be taken for such dividend, distribution, subscription rights (specifying the date on which the holders of Preferred Stock shall be entitled thereto) or for determining rights to vote in respect of such Merger
Event, dissolution, liquidation or winding up; (B) in the case of any such Merger Event, sale, lease, license or other transfer of all or substantially all assets, dissolution, liquidation or winding up, at least thirty (30) days’
prior written notice of the date when the same shall take place (and specifying the date on which the holders of Preferred Stock shall be entitled to exchange their Preferred Stock for securities or other property deliverable upon such Merger Event,
dissolution, liquidation or winding up); and (C) in the case of an Initial Public Offering, the Company shall give the Warrantholder at least thirty (30) days’ written notice prior to the effective date thereof. 

Each such written notice shall set forth, in reasonable detail, (i) the event requiring the notice, and (ii) if any adjustment is required to be
made, (A) the amount of such adjustment, (B) the method by which such adjustment was calculated, (C) the adjusted Exercise Price (if the Exercise Price has been adjusted), and (D) the number of shares subject to purchase
hereunder after giving effect to such adjustment, and shall be given by first class mail, postage prepaid, or by reputable overnight courier with all charges prepaid, addressed to the Warrantholder at the address for Warrantholder set forth in the
registry referred to in Section 7. 
 (h)    Timely Notice. Failure to timely provide such notice required
by subsection (g) above shall entitle Warrantholder to retain the benefit of the applicable notice period notwithstanding anything to the contrary contained in any insufficient notice received by Warrantholder. For purposes of this
subsection (h), and notwithstanding anything to the contrary in Section 12(g), the notice period shall begin on the date Warrantholder actually receives a written notice containing all the information required to be provided in such
subsection (g). 
 SECTION 9.    REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY. 

(a)    Reservation of Preferred Stock. The Preferred Stock issuable upon exercise of the Warrantholder’s rights
has been or, in the case of Preferred Stock issuable in the Next Round, will be duly and validly reserved and, when issued in accordance with the provisions of this Agreement, will be validly issued, fully paid and
non-assessable, and will be free of any taxes, liens, charges or encumbrances of any nature whatsoever; provided, that the Preferred Stock issuable pursuant to this Agreement may be subject to
restrictions on transfer under state and/or federal securities laws. The Company has made available to the Warrantholder true, correct and complete copies of its Charter and current bylaws. The issuance of certificates for shares of Preferred Stock
upon exercise of this Agreement shall be made without charge to the Warrantholder for any issuance tax in respect thereof, or other cost incurred by the Company in connection with such exercise and the related issuance of shares of Preferred Stock;
provided, that the Company shall not be required to pay any tax which may be payable in respect of any transfer and the issuance and delivery of any certificate in a name other than that of the Warrantholder. 

(b)    Due Authority. The execution and delivery by the Company of this Agreement and the performance of all
obligations of the Company hereunder, including the issuance to Warrantholder of the right to acquire the shares of Preferred Stock and the Common Stock into which it may be converted, 

  
 6 

 
have been duly authorized by all necessary corporate action on the part of the Company. This Agreement: (1) does not violate the Company’s Charter or current bylaws; (2) does not
contravene any law or governmental rule, regulation or order applicable to it; and (3) does not and will not contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument to which it is a
party or by which it is bound. This Agreement constitutes a legal, valid and binding agreement of the Company, enforceable in accordance with its terms. 

(c)      Consents and Approvals. No consent or approval of, giving of notice to, registration with, or
taking of any other action in respect of any state, federal or other governmental authority or agency is required with respect to the execution, delivery and performance by the Company of its obligations under this Agreement, except for the filing
of notices pursuant to Regulation D under the Act and any filing required by applicable state securities law, which filings will be effective by the time required thereby. 

(d)      Issued Securities. All issued and outstanding shares of Common Stock, Preferred Stock or any
other securities of the Company have been duly authorized and validly issued and are fully paid and nonassessable. All outstanding shares of Common Stock, Preferred Stock and any other securities were issued in full compliance with all federal and
state securities laws. In addition, as of the date immediately preceding the date of this Agreement: 

(i)      The authorized capital of the Company consists of (A) 175,000,000 shares of Common Stock, of which
19,461,158 shares are issued and outstanding, and (B) 93,050,000 shares of Preferred Stock, of which 80,129,964 shares are issued and outstanding and are convertible into 112,450,836 shares of Common Stock. 

(ii)     The Company has reserved 32,538,335 shares of Common Stock for issuance under its Stock Option Plan(s),
under which 20,371,270 options are outstanding. There are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued shares of the Company’s capital stock
or other securities of the Company. The Company has no outstanding loans to any employee, officer or director of the Company, and the Company agrees not to enter into any such loan or otherwise guarantee the payment of any loan made to an employee,
officer or director by a third party. 
 (iii)    In accordance with the Company’s Charter, no shareholder of the
Company has preemptive rights to purchase new issuances of the Company’s capital stock. 

(e)      Registration Rights Agreement. The Company agrees to amend that certain Amended and Restated
Investors’ Rights Agreement dated as of June 18, 2012 by and among the Company and certain of its stockholders identified therein (the “Rights Agreement”) in connection with the Next Round such that the shares of Preferred
Stock, if any, issued upon the exercise Warrantholder’s rights under this Agreement shall be entitled to registration rights as set forth the Rights Agreement. 

(f)      Other Commitments to Register Securities. Except as set forth in this Agreement and the
Registration Rights Agreement, the Company is not, pursuant to the terms of any other agreement currently in existence, under any obligation to register under the Act any of its presently outstanding securities or any of its securities which may
hereafter be issued. 
 (g)      Exempt Transaction. Subject to the accuracy of the
Warrantholder’s representations in Section 10, the issuance of the Preferred Stock upon exercise of this Agreement, and the issuance of the Common Stock upon conversion of the Preferred Stock, will each constitute a transaction exempt from
(i) the registration requirements of Section 5 of the Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements of the applicable state securities laws. 

(h)      Compliance with Rule 144. If the Warrantholder proposes to sell Preferred Stock issuable upon
the exercise of this Agreement, or the Common Stock into which it is convertible, in 

  
 7 

 
compliance with Rule 144 promulgated by the SEC, then, upon Warrantholder’s written request to the Company, the Company shall furnish to the Warrantholder, within ten days after receipt of
such request, a written statement confirming the Company’s compliance with the filing requirements of the SEC as set forth in such Rule, as such Rule may be amended from time to time. 

(i)    Information Rights. During the term of this Warrant, Warrantholder shall be entitled to the information
rights contained in Section 7.1 of the Loan Agreement, and Section 7.1 of the Loan Agreement is hereby incorporated into this Agreement by this reference as though fully set forth herein, provided, however, that the Company shall not be
required to deliver a Compliance Certificate once all Indebtedness (as defined in the Loan Agreement) owed by the Company to Warrantholder has been repaid. 

SECTION 10.    REPRESENTATIONS AND COVENANTS OF THE WARRANTHOLDER. 

This Agreement has been entered into by the Company in reliance upon the following representations and covenants of the Warrantholder: 

(a)    Investment Purpose. The right to acquire Preferred Stock is being acquired for investment and not with a
view to the sale or distribution of any part thereof, and the Warrantholder has no present intention of selling or engaging in any public distribution of such rights or the Preferred Stock except pursuant to an effective registration statement or an
exemption from the registration requirements of the Act. 
 (b)    Private Issue. The Warrantholder understands
(i) that the Preferred Stock issuable upon exercise of this Agreement is not registered under the Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Agreement will be exempt from the
registration and qualifications requirements thereof, and (ii) that the Company’s reliance on such exemption is predicated on the representations set forth in this Section 10. 

(c)    Financial Risk. The Warrantholder has such knowledge and experience in financial and business matters as to
be capable of evaluating the merits and risks of its investment, and has the ability to bear the economic risks of its investment. 

(d)    Risk of No Registration. The Warrantholder understands that if the Company does not register with the SEC
pursuant to Section 12 of the Securities Exchange Act of 1934 (the “1934 Act”), or file reports pursuant to Section 15(d) of the 1934 Act, or if a registration statement covering the securities under the Act is not in
effect when it desires to sell (i) the rights to purchase Preferred Stock pursuant to this Agreement or (ii) the Preferred Stock issuable upon exercise of the right to purchase, it may be required to hold such securities for an indefinite
period. The Warrantholder also understands that any sale of (A) its rights hereunder to purchase Preferred Stock or (B) Preferred Stock issued or issuable hereunder which might be made by it in reliance upon Rule 144 under the Act may be
made only in accordance with the terms and conditions of that Rule. 
 (e)    Accredited Investor. Warrantholder
is an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D, as presently in effect. 

SECTION 11.    TRANSFERS. 

(a)    Subject to compliance with applicable federal and state securities laws, this Agreement and all rights hereunder are
transferable, in whole or in part, without charge to the holder hereof (except for transfer taxes) upon surrender of this Agreement properly endorsed. Each taker and holder of this Agreement, by taking or holding the same, consents and agrees that
this Agreement, when endorsed in blank, shall be deemed negotiable, and that the holder hereof, when this Agreement shall have been so endorsed and its transfer recorded on the Company’s books, shall be treated by the Company and all other
persons dealing with this Agreement as the absolute owner hereof for any purpose and as the person entitled to exercise the rights represented by this Agreement. The transfer of this Agreement shall be recorded on the books of the Company upon
receipt by the Company of a notice of transfer in the form attached hereto as 

  
 8 

 
Exhibit III (the “Transfer Notice”), at its principal offices and the payment to the Company of all transfer taxes and other governmental charges imposed on such transfer. Until
the Company receives such Transfer Notice, the Company may treat the registered owner hereof as the owner for all purposes. 

(b)    Notwithstanding anything to the contrary in Section 11(a) or elsewhere in this Agreement, the Warrantholder
agrees to be bound by the provisions of the “Market Stand-off Agreement” in Section 2.14 of that certain Amended and Restated Investors’ Rights Agreement dated as of June 18, 2012 by
and among the Company and certain of its stockholders identified therein (the “Rights Agreement”). The Warrantholder acknowledges that it has received a true and complete copy of the Rights Agreement. 

(c)    Further notwithstanding anything to the contrary in Section 11(a) or elsewhere in this Agreement, the
Warrantholder agrees to be bound by the transfer restrictions in Section 36 of the Company’s Amended and Restated Bylaws (the “Bylaws”), such that neither this Agreement nor the shares of Preferred Stock, if any, issued
upon the exercise Warrantholder’s rights under this Agreement shall be transferrable except in accordance with Section 36 of the Bylaws. The Warrantholder acknowledges that it has received a true and complete copy of the Bylaws. 

SECTION 12.    MISCELLANEOUS. 

(a)    Effective Date. The provisions of this Agreement shall be construed and shall be given effect in all respects
as if it had been executed and delivered by the Company on the date hereof. This Agreement shall be binding upon any successors or assigns of the Company. 

(b)    Remedies. In the event of any default hereunder, the non-defaulting
party may proceed to protect and enforce its rights either by suit in equity and/or by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where
Warrantholder will not have an adequate remedy at law and where damages will not be readily ascertainable. The Company expressly agrees that it shall not oppose an application by the Warrantholder or any other person entitled to the benefit of this
Agreement requiring specific performance of any or all provisions hereof or enjoining the Company from continuing to commit any such breach of this Agreement. 

(c)    No Impairment of Rights. The Company will not, by amendment of its Charter or through any other means, avoid
or seek to avoid the observance or performance of any of the terms of this Agreement, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate in order
to protect the rights of the Warrantholder against impairment. 
 (d)    Additional Documents. The Company, upon
execution of this Agreement, shall provide the Warrantholder with certified resolutions with respect to the representations, warranties and covenants set forth in Sections 9(a) through 9(d), 9(f) and 9(g). The Company shall also supply such other
documents as the Warrantholder may from time to time reasonably request. 
 (e)    Attorney’s Fees. In any
litigation, arbitration or court proceeding between the Company and the Warrantholder relating hereto, the prevailing party shall be entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Agreement. For
the purposes of this Section 12(e), attorneys’ fees shall include without limitation fees incurred in connection with the following: (i) contempt proceedings; (ii) discovery; (iii) any motion, proceeding or other activity of any
kind in connection with an insolvency proceeding; (iv) garnishment, levy, and debtor and third party examinations; and (v) post-judgment motions and proceedings of any kind, including without limitation any activity taken to collect or
enforce any judgment. 
 (f)    Severability. In the event any one or more of the provisions of this Agreement
shall for any reason be held invalid, illegal or unenforceable, the remaining provisions of this Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and
enforceable provision, which comes closest to the intention of the parties underlying the invalid, illegal or unenforceable provision. 

  
 9 

 (g)    Notices. Except as otherwise provided herein, any notice,
demand, request, consent, approval, declaration, service of process or other communication that is required, contemplated, or permitted under this Agreement or with respect to the subject matter hereof shall be in writing, and shall be deemed to
have been validly served, given, delivered, and received upon the earlier of: (i) the day of transmission by facsimile or hand delivery if transmission or delivery occurs on a business day at or before 5:00 pm in the time zone of the recipient,
or, if transmission or delivery occurs on a non-business day or after such time, the first business day thereafter, or the first business day after deposit with an overnight express service or overnight mail
delivery service; or (ii) the third calendar day after deposit in the United States mails, with proper first class postage prepaid, and shall be addressed to the party to be notified as follows: 

If to Warrantholder: 
 HERCULES TECHNOLOGY GROWTH
CAPITAL, INC. 
 Legal Department 

Attention: Chief Legal Officer and Manuel Henriquez 

400 Hamilton Avenue, Suite 310 

Palo Alto, CA 94301 
 Facsimile: 650-473-9194 
 Telephone: 650-289-3060 
 If to the Company: 

PROGRESO FINANCIERO HOLDINGS, INC. 

Attention: Scott Harvey 
 171
Constitution Drive 
 Menlo Park, CA 94025 

Facsimile: 650-391-0214 

Telephone: 650-776-0191 

or to such other address as each party may designate for itself by like notice. 

(h)    Entire Agreement; Amendments. This Agreement constitute the entire agreement and understanding of the
parties hereto in respect of the subject matter hereof, and supersede and replace in their entirety any prior proposals, term sheets, letters, negotiations or other documents or agreements, whether written or oral, with respect to the subject matter
hereof (including Lender’s proposal letter dated June 19, 2013). None of the terms of this Agreement may be amended except by an instrument executed by each of the parties hereto. 

(i)    Headings. The various headings in this Agreement are inserted for convenience only and shall not affect the
meaning or interpretation of this Agreement or any provisions hereof. 
 (j)    Advice of Counsel. Each of the
parties represents to each other party hereto that it has discussed (or had an opportunity to discuss) with its counsel this Agreement and, specifically, the provisions of Sections 12(n), 12(o), 12(p). 12(q) and 12(r). 

(k)    No Strict Construction. The parties hereto have participated jointly in the negotiation and drafting of this
Agreement. In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any provisions of this Agreement. 
 (l)    No Waiver. No omission or delay by
Warrantholder at any time to enforce any right or remedy reserved to it, or to require performance of any of the terms, covenants or provisions hereof by the Company at any time designated, shall be a waiver of any such right or remedy to which
Warrantholder is entitled, nor shall it in any way affect the right of Warrantholder to enforce such provisions thereafter. 

  
 10 

 (m)    Survival. All agreements, representations and warranties
contained in this Agreement or in any document delivered pursuant hereto shall be for the benefit of Warrantholder and shall survive the execution and delivery of this Agreement and the expiration or other termination of this Agreement. 

(n)    Governing Law. This Agreement have been negotiated and delivered to Warrantholder in the State of
California, and shall have been accepted by Warrantholder in the State of California. Delivery of Preferred Stock to Warrantholder by the Company under this Agreement is due in the State of California. This Agreement shall be governed by, and
construed and enforced in accordance with, the laws of the State of California, excluding conflict of laws principles that would cause the application of laws of any other jurisdiction. 

(o)    Consent to Jurisdiction and Venue. All judicial proceedings arising in or under or related to this Agreement
may be brought in any state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this Agreement, each party hereto generally and unconditionally: (a) consents to personal jurisdiction in
Santa Clara County, State of California; (b) waives any objection as to jurisdiction or venue in Santa Clara County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts;
and (d) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Agreement. Service of process on any party hereto in any action arising out of or relating to this Agreement shall be effective if given in
accordance with the requirements for notice set forth in Section 12(g), and shall be deemed effective and received as set forth in Section 12(g). Nothing herein shall affect the right to serve process in any other manner permitted by law
or shall limit the right of either party to bring proceedings in the courts of any other jurisdiction. 

(p)    Mutual Waiver of Jury Trial. Because disputes arising in connection with complex financial transactions are
most quickly and economically resolved by an experienced and expert person and the parties wish applicable state and federal laws to apply (rather than arbitration rules), the parties desire that their disputes be resolved by a judge applying such
applicable laws. EACH OF THE COMPANY AND WARRANTHOLDER SPECIFICALLY WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY, “CLAIMS”)
ASSERTED BY THE COMPANY AGAINST WARRANTHOLDER OR ITS ASSIGNEE OR BY WARRANTHOLDER OR ITS ASSIGNEE AGAINST THE COMPANY. This waiver extends to all such Claims, including Claims that involve Persons other than Borrower and Lender; Claims that arise
out of or are in any way connected to the relationship between the Company and Warrantholder; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind, arising out of this Agreement. 

(q)     Judicial Reference. If the waiver of jury trial set forth above is ineffective or unenforceable, the
parties agree that all Claims shall be resolved by reference to a private judge sitting without a jury, pursuant to Code of Civil Procedure Section 638, before a mutually acceptable referee or, if the parties cannot agree, a referee selected by
the Presiding Judge of Santa Clara County, California. Such proceeding shall be conducted in Santa Clara County, California, with California rules of evidence and discovery applicable to such proceeding. 

(r)    Prejudgment Relief. In the event Claims are to be resolved by arbitration, either party may seek from a
court of competent jurisdiction identified in Section 12(o), any prejudgment order, writ or other relief and have such prejudgment order, writ or other relief enforced to the fullest extent permitted by law notwithstanding that all Claims are
otherwise subject to resolution by judicial reference. 
 (s)    Counterparts. This Agreement and any amendments,
waivers, consents or supplements hereto may be executed in any number of counterparts, and by different parties hereto in separate counterparts, each of which when so delivered shall be deemed an original, but all of which counterparts shall
constitute but one and the same instrument. 

  
 11 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by its officers
thereunto duly authorized as of the Effective Date. 
  

							
	 COMPANY:
	 		 	PROGRESO FINANCIERO HOLDINGS, INC.
				
		 		 	By:	 	  

		 		 	Name:	 	Jonathan Coblentz
		 		 	Title:	 	Chief Financial Officer
			
	 WARRANTHOLDER:
	 		 	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	

 EXHIBIT I 

NOTICE OF EXERCISE 
  

	To:	 PROGRESO FINANCIERO HOLDINGS, INC. 

 

	(1)	 The undersigned Warrantholder hereby elects to purchase
[            ] shares of the Series [    ] Preferred Stock of
[                    ], pursuant to the terms of the Agreement dated [            ] (the
“Agreement”) between PROGRESO FINANCIERO HOLDINGS, INC. and the Warrantholder, and [CASH PAYMENT: tenders herewith payment of the Purchase Price in full, together with all applicable transfer taxes, if any.] [NET ISSUANCE: elects pursuant
to Section 3(a) of the Agreement to effect a Net Issuance.] 

  

	(2)	 Please issue a certificate or certificates representing said shares of Series [    ]
Preferred Stock in the name of the undersigned or in such other name as is specified below. 

  

							
		 		 	  

		 		 	(Name)	 	
			
		 		 	  

		 		 	(Address)
			
	WARRANTHOLDER:	 		 	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.

 
							
				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	
		 		 	Date:	 	

 EXHIBIT II 

ACKNOWLEDGMENT OF EXERCISE 
 The undersigned
[PROGRESO FINANCIERO HOLDINGS, INC.], hereby acknowledge receipt of the “Notice of Exercise” from Hercules Technology Growth Capital, Inc., to purchase [        ] shares of the Series
[    ] Preferred Stock of PROGRESO FINANCIERO HOLDINGS, INC., pursuant to the terms of the Agreement, and further acknowledges that [            ] shares remain subject
to purchase under the terms of the Agreement. 
  

					
	 COMPANY:
	 	PROGRESO FINANCIERO HOLDINGS, INC.

					
			
		 	By:	 	  

		 	Title:	 	
		 	 Date:
	 	

 EXHIBIT III 

TRANSFER NOTICE 
 (To transfer or assign the
foregoing Agreement execute this form and supply required information. Do not use this form to purchase shares.) 
 FOR VALUE RECEIVED, the foregoing
Agreement and all rights evidenced thereby are hereby transferred and assigned to 
  

					
	  
	 	
	(Please Print)	 	
			
	whose address is	 	  
	 	
		
	      
	 	

 
			
		
	
Dated:                  
                                         
                                         
              
	 	
		
	 Holder’s
Signature:                                       
                                         
             
	 	
		
	 Holder’s
Address:                                       
                                         
               
	 	
		
	  
	 	

					
			
	 Signature Guaranteed:
	 	  
	  	

 NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Agreement, without
alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Agreement. 

  
 15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00297-of-00352.parquet"}]]